dijous, 21 d’agost del 2014

Will Medtronic abandon inversion in Covidien deal? | Medtech Wall Street news for the week of August 18, 2014




Here's a look at some of the top Wall Street stories for medical device companies this week: Will Medtronic follow Walgreen and abandon inversion in Covidien deal?; ElectroCore seeks commercial partners for non-invasive headache tech; Allergan-Valeant update: SEC launches Ackman probe, Allergan pays up to $588M for Liris bladder drug, Ackman dangles IPO; Activist investor battles on over ConMed as shareholders vote approaches; Medtronic's Q1 earnings beat The Street on modest sales bump






Will Medtronic follow Walgreen and abandon inversion in Covidien deal?


August 15, 2014 by Brad Perriello




read more






from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1neBVhX

Cap comentari:

Publica un comentari a l'entrada